Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

ALL-REZ BFM 2002 Is Associated with Improved Outcome as Compared to ALL-R3 Strategy in Children with Standard Risk Isolated CNS Relapse of Acute Lymphoblastic Leukemia, while Maintaining Comparable Efficacy in Patients with Bone Marrow Relapse. Results of the Multi-National, Multi-Center Trial IntReALL SR 2010

Blood (2022) 140 (Supplement 1): 3247–3249.

https://doi.org/10.1182/blood-2022-166234

Published: 2022

Journal Articles

Modeling Relapsed, Refractory Acute Lymphoblastic Leukemia from a Child with Neurofibromatosis

Susan L Heatley, Elyse C Page, Laura N Eadie, Barbara J McClure, Jacqueline Rehn, David T Yeung, Michael Philip Osborn, Tamas Revesz, Maria Kirby, Deborah L White

Blood (2021) 138 (Supplement 1): 1317.

https://doi.org/10.1182/blood-2021-150086

Published: 2021

Journal Articles

Poor Prognosis in Children with ABL -Class Fusion Positive B-Cell Acute Lymphoblastic Leukemia Treated According to AIEOP-BFM Protocols

Blood (2019) 134 (Supplement_1): 1351.

https://doi.org/10.1182/blood-2019-126523

Published: 2019

Journal Articles

Clinical and Germline Risk Factors for the Occurrence of Multiple Treatment Toxicities during Childhood Acute Lymphoblastic Leukemia (ALL) Therapy

Marion K Mateos, MBBS FRACP, Toby N Trahair, MBBS FRACP PhD, Chelsea Mayoh, BSc, Pasquale M Barbaro, MBBS FRACP FRCPA, Carly George, MBBS, FRACP, Rosemary Sutton, PhD, Tamas Revesz, MDPhDD.Sc FRACP FRCPA, Draga Barbaric, MBBS FRACP, Jodie Giles, Frank Alvaro, FRACP, MBBS, Francoise Marie Mechinaud, MD FRACP, Daniel R Catchpoole, PhD BSc, Rishi Sury Kotecha, MBBChir, MRCP, FRACP, PhD, Michael CJ Quinn, BSc MSc PhD, Georgia Chenevix-Trench, BSc PhD, Stuart MacGregor, BSc MSc PhD, Luciano Dalla-Pozza, MBBS FRACP, Glenn M Marshall, MBBS, MD FRACP

Blood (2017) 130 (Supplement 1): 2102.

https://doi.org/10.1182/blood.V130.Suppl_1.2102.2102

Published: 2017

Journal Articles

Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia

Marion K Mateos, MBBS FRACP, Toby N. Trahair, MBBS FRACP PhD, Chelsea Mayoh, BSc, Pasquale M Barbaro, MBBS FRACP FRCPA, Rosemary Sutton, BSc PhD, Tamas Revesz, MD PhDD.Sc FRACP FRCPA, Draga Barbaric, MBBS FRACP, Jodie Giles, Frank Alvaro, MBBS, FRACP, Francoise Mechinaud, MD FRACP, Daniel Catchpoole, BSc PhDFFSc(RCPA), Rishi S Kotecha, MB ChB FRACP PhD, Luciano Dalla-Pozza, MB BS FRACP, Glenn M Marshall, MBBS, MD FRACP

Blood (2016) 128 (22): 1182.

https://doi.org/10.1182/blood.V128.22.1182.1182

Published: 2016

Journal Articles

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

Blood (2016) 128 (7): 911–922.

https://doi.org/10.1182/blood-2016-03-704973

Published: 2016

Includes: Supplemental data

Journal Articles

Improved Concordance of Minimal Residual Disease Measurements By Quantitative PCR and 10-Color Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia

Mary Sartor, PhD, Draga Barbaric, MBBS, Tamara Law, BSc (Hons), DR Anuruddhika Dissanayake, PhD, Nicola C Venn, Mawar Karsa, BSc (Hons), MSc, Sue W J Wong, BSc, MSc(MD, Murray D Norris, PhD, Tamas Revesz, MD PhD, Petra Ritchie, MBBS, Peter J Shaw, Kenneth F Bradstock, MBBS PhDFRACP FRCPA, Luciano Dalla Pozza, MBBS, FRACP, Toby N Trahair, PhD MBBS, Rosemary Sutton, PhD

Blood (2015) 126 (23): 2614.

https://doi.org/10.1182/blood.V126.23.2614.2614

Published: 2015

Journal Articles

High Prevalence of Relapse in Australian Children with Ph-like Acute Lymphoblastic Leukemia Despite Risk Adapted Treatment

Blood (2015) 126 (23): 1419.

https://doi.org/10.1182/blood.V126.23.1419.1419

Published: 2015

Journal Articles

The Clinical Relevance Of Genetics In Predicting Outcome After a First Relapse In Children With B-Cell Precursor Acute Lymphoblastic Leukaemia

Anthony V. Moorman, Amy Erhorn, Catriona Parker, Rosemary Sutton, Claire Schwab, BSc, Nicola C Venn, Peter M. Hoogerbrugge, Tamas Revesz, Vaskar Saha, Christine J Harrison, PhD

Blood (2013) 122 (21): 2566.

https://doi.org/10.1182/blood.V122.21.2566.2566

Published: 2013

Journal Articles

Ethylene Diamine Tetra Acetic Acid (EDTA) Decalcification of Paediatric Bone Marrow Trephines In a Diagnostic Laboratory

Shriram Vaidia Nath, FRCPA, DM, MD, D.Ped, MBBS, Michelle Tamblyn, Dip., Med., Tech, Grad, Cert, Surg, Path, Prep, Susan Telfer, BSc(Hons), Grad, Cert, Surg, Path, Prep, Tony Henwood, JP, MSc, BAppSc, GradDipSysAnalys, CT(ASC), Peter Gilham, Colin Story, MSc, Greg Hodge, PhD, Akash Kalro, FRCPA, Michael Osborn, MBBS, FRACP, FRCPA, Ram Suppiah, MBBS, FRACP, FRCPA, Heather Tapp, MBBS, FRACP, FRCPA, Ian C Nicholson, PhD, BSc(Hons), BSc, Heddy Zola, PhD, FRCPA, Sarah Moore, B, App, Sci, BSc(Hons), Andrew Zannettino, BSc, PhD, Nick Manton, FRCPA, Tamas Revesz, MD, PhD, FRACP

Blood (2010) 116 (21): 2566.

https://doi.org/10.1182/blood.V116.21.2566.2566

Published: 2010

Journal Articles

Mitoxantrone Improves the Outcome of Children with Central Nervous System (CNS) Involvement at First Relapse of Acute Lymphoblastic Leukemia (ALL)-Results of the International ALLR3 Study

Ashish Narayan Masurekar, Catriona Anne Parker, BSc, MSc, PhD, Satarupa Choudhuri, Carly Leighton, Jeremy Hancock, Rosemary Sutton, Anthony V. Moorman, PhD, Phil Ancliff, Mary Morgan, MD, Nicholas Goulden, Nina Green, Tamas Revesz, MD, PhD, FRACP, Peter Hoogerbrugge, MD, PhD, Philip Darbyshire, Sharon Love, Vaskar Saha

Blood (2010) 116 (21): 3303.

https://doi.org/10.1182/blood.V116.21.3303.3303

Published: 2010

Journal Articles

Mitoxantrone, Not Idarubicin, Significantly Improves the Outcome of Children with Relapsed ALL – Result of the International, Randomised ALLR3 Study.

Catriona Parker, Rachel Waters, Carly Leighton, Jeremy Hancock, Anthony Moorman, Mary Morgan, Philip Ancliff, Nicholas Goulden, Rosemary Sutton, Tamas Revesz, Philip Darbyshire, Sharon Love, Vaskar Saha

Blood (2009) 114 (22): 3390.

https://doi.org/10.1182/blood.V114.22.3390.3390

Published: 2009

NARROW

Modeling Relapsed, Refractory Acute Lymphoblastic Leukemia from a Child with Neurofibromatosis

Poor Prognosis in Children with ABL -Class Fusion Positive B-Cell Acute Lymphoblastic Leukemia Treated According to AIEOP-BFM Protocols

Clinical and Germline Risk Factors for the Occurrence of Multiple Treatment Toxicities during Childhood Acute Lymphoblastic Leukemia (ALL) Therapy

Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

Improved Concordance of Minimal Residual Disease Measurements By Quantitative PCR and 10-Color Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia

High Prevalence of Relapse in Australian Children with Ph-like Acute Lymphoblastic Leukemia Despite Risk Adapted Treatment

The Clinical Relevance Of Genetics In Predicting Outcome After a First Relapse In Children With B-Cell Precursor Acute Lymphoblastic Leukaemia

Ethylene Diamine Tetra Acetic Acid (EDTA) Decalcification of Paediatric Bone Marrow Trephines In a Diagnostic Laboratory

Mitoxantrone Improves the Outcome of Children with Central Nervous System (CNS) Involvement at First Relapse of Acute Lymphoblastic Leukemia (ALL)-Results of the International ALLR3 Study

Mitoxantrone, Not Idarubicin, Significantly Improves the Outcome of Children with Relapsed ALL – Result of the International, Randomised ALLR3 Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only